Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Moodys
Express Scripts
McKesson
US Army
Novartis
Cipla
Farmers Insurance
QuintilesIMS
Medtronic

Generated: January 16, 2018

DrugPatentWatch Database Preview

Watson Labs Company Profile

« Back to Dashboard

What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?

WATSON LABS has one thousand one hundred and twelve approved drugs.

There are twenty-three tentative approvals on WATSON LABS drugs.

Summary for Watson Labs
US Patents:0
Tradenames:413
Ingredients:383
NDAs:1112

Drugs and US Patents for Watson Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride SUPPOSITORY;RECTAL 040479-001 Jun 24, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 086728-001 Oct 5, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 085139-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 083667-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs GLIPIZIDE glipizide TABLET, EXTENDED RELEASE;ORAL 076467-001 Sep 8, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070378-001 Mar 19, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 084441-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PIROXICAM piroxicam CAPSULE;ORAL 074287-001 May 16, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET;ORAL 078551-004 Oct 8, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs THIAMINE HYDROCHLORIDE thiamine hydrochloride INJECTABLE;INJECTION 083534-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Chubb
Fish and Richardson
Baxter
Dow
Boehringer Ingelheim
Novartis
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot